Logo Cegat neu 2021

CeGaT GmbH

CeGaT is a provider of genetic diagnostics and NGS services.

CeGaT is a global provider of genetic analyses for a wide range of medical, research, and pharmaceutical applications.

Founded in 2009 in Tübingen, Germany, the company combines stateof-the-art sequencing technology with medical expertise - with the aim of identifying the genetic causes of diseases and supporting patient care. For researchers and pharmaceutical companies, CeGaT offers a broad portfolio of sequencing services and tumor analysis. CeGaT generates the data basis for clinical studies and medical innovations and drives science forward with its own insights.

The owner-managed company stands for independence, comprehensive personal customer service, and outstanding quality. CeGaT‘s laboratory is accredited according to CAP/CLIA and DIN EN ISO 15189, and thus meets the highest international standards. In order to obtain first-class results, all processes are carried out in-house under scientific supervision.

Category Biotechnology
Working areas Biotechnology, Diagnostics, Genetics, Oncology, Sequencing
Year of foundation
2009
Employees
> 100

News

16.11.2023

CeGaT Revolutionizes Exome Diagnostics with Genome-wide CNV Analysis

Tübingen: CeGaT, a global provider of genetic diagnostics and sequencing services, presents an innovation in exome diagnostics: With the integration of a CNV backbone, it is now…

01.06.2023

CeGaT and Twist Bioscience Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research

RNA fusions can be used as biomarkers to identify cancer sub-types and monitor for residual disease

01.06.2023

CeGaT and Twist Bioscience Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research

Tübingen –  CeGaT GmbH, a global provider of sequencing services for research, clinical studies, and human genetic diagnostics, and Twist Bioscience Corporation (NASDAQ: TWST), a…

04.05.2023

New Service: Single-Cell Immune Profiling for an In-Depth Understanding of the Immune System

CeGaT’s Research and Pharma Solutions business unit has launched Single-Cell Immune Profiling, a new product to study the immune system on single-cell resolution. By providing…